ArticleNature communications2026
Cobalt-catalyzed asymmetric three-component reductive addition of alkynes with alkyl halides and imines.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The catalytic dicarbofunctionalization of alkynes is a highly efficient strategy for the rapid assembly of complex, multi-substituted acyclic alkenes from simple feedstocks. Despite significant progress having been made in various racemic transformations, the direct enantioselective construction of multi-substituted acyclic alkenes bearing sterically congested tetrasubstituted stereocenters via multicomponent radical pathways remains a formidable and unsolved challenge in organic chemistry. Herein, we report a cobalt-catalyzed asymmetric three-component radical addition of terminal alkynes, ketimines, and unactivated alkyl iodides, which efficiently delivers polysubstituted allylamine derivatives featuring challenging tetrasubstituted stereocenters. This enantioselective addition protocol proceeds under mild reductive conditions and exhibits broad substrate scope with high functional group tolerance, delivering products with excellent stereoselectivity. Preliminary mechanistic investigations suggest a radical-based cascade process involving stereospecific alkyl radical addition to the alkyne followed by stereoselective addition to the ketimine. This work provides a straightforward and modular strategy to access highly functionalized chiral allylic amines from readily available starting materials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.